FDA Approves HYDROCHLOROTHIAZIDE — Advagen Pharma Ltd

Advagen Pharma Ltd announced the FDA approval of its application (ANDA218248) to manufacture the generic version of oral Hydrochlorothiazide, a widely prescribed diuretic. This launch is expected to inject significant generic competition into the diuretic market, potentially shifting market dynamics and pressuring branded pricing strategies.